DaVita Inc. vs Abbvie Inc.
DVA vs ABBV — side-by-side comparison from reported financials. DVA leads 6, ABBV leads 4 of 10 comparable metrics.
DaVita Inc.
DVA · Healthcare
$179.25+1.26%Strained
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | DVA | ABBV |
|---|---|---|
| Price | $179.25 | $276.43 |
| Market cap | $11.4B | $488B |
| Revenue (TTM) | $14.0B | $64.4B |
| Revenue growth | +5.5% | +1.8% |
| Net margin | 6.0% | 9.8% |
| Free cash flow | $1.61B | $18.2B |
| Net cash (debt) | ($9.57B) | ($56.2B) |
| 1-year price return | +41.8% | +19.8% |
| P/E | 13.5 | 77.4 |
| P/E vs own history (cheap-side %) | 54% | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | 181% | 96% |
| Altman Z-score | — | 2.33 |
| CV checks passed | 8 of 10 | 9 of 10 |
| Employees | 78,000 | 57,000 |
Full résumé-style profiles: DVA CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.